Description:

Cycle Dose Drug Form, GOG-0209, Form D2R Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer NCT00063999 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B2402FA9-5BBE-0F62-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B2402FA9-5BBE-0F62-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 8/27/12
  2. 1/8/15
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Cycle Dose Drug Form D2R Endometrial Cancer (NCT00063999)

No Instruction available.

  1. StudyEvent: Cycle Dose Drug Form, GOG-0209, Form D2R
    1. No Instruction available.
Header Module
Treatment Cycle And Modification
Cycle delayed
Were there any dose modifications or additions/omissions to protocol treatment (* 1 =Yes, planned, 2 =Yes, unplanned, 3 =No)
Kg
Performance status (Zubrod)
g/dL
mg/dL

Similar models